Current therapy of acute heart failure-Reference-Cited by-同舟云学术

Current therapy of acute heart failure

Published:1988-11 Issue:S1 Volume:2 Page:401-406
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drug Ther

Author:

Rettig Gerd F.,Bette Ludwig

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00633420.pdf

Reference13 articles.

1. WeberKT, JanickiJS, RussellRO, et al. Identification of high risk subsets of acute myocardial infarction.Am J Cardiol 1979; 41: 197–203.

2. LoebHS, BredakisJ, GunnarRM. Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.Circulation 1977; 55: 375–381.

3. LeierCV, HebanP, HussP, et al. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.Circulation 1978; 58: 466–475.

4. FowlerMB, AldermanEL, OesterleSN, et al. Dobutamine and dopamine after cardiac surgery: Greater augmentation of myocardial blood flow with dobutamine.Circulation 1984; 70(Suppl 1): 103.

5. BristowMR, GinsburgR, MonobeW, et al. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts.N Engl J Med 1982; 307: 205–211.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction between inhalational anaesthetics and enoximone on isolated heart muscle;General Pharmacology: The Vascular System;1993-07

2. Therapie des akuten Herzversagens;Refresher Course — Aktuelles Wissen für Anästhesisten;1993

3. Phosphodiesterase-Inhibitors for Treating Low-Output Syndrome;Yearbook of Intensive Care and Emergency Medicine;1992

4. Medikamentöse Therapie des myokardialen Pumpversagens („low-output failure“);Der kardiale Risikopatient in der operativen Medizin;1992

5. Pharmacological and biochemical effects of the cardiotonic agent Org10325 in isolated cardiac and vascular tissue preparations;British Journal of Pharmacology;1990-08